Infectious disease test kit BCID2

for blood diseasesblood culturefor identification analysis

This multiplex PCR test detects pathogens and antimicrobial resistance genes commonly associated with bloodstream infections (BSI). Help inform sepsis treatment with comprehensive results in about an hour from a positive blood culture. A New Kind of Blood Culture Identification The BIOFIRE® Blood Culture Identification 2 (BCID2) Panel tests a single positive blood culture sample to simultaneously provide results for multiple organisms and organism groups that cause bloodstream infections, as well as genetic markers associated with antimicrobial resistance. Within about an hour from the positive blood culture, the test delivers these comprehensive results in a single report. The Power Behind the Panel The BIOFIRE BCID2 Panel can provide the essential combination of speed, accuracy, and comprehensiveness to enable the fast identification of probable pathogen directly from positive blood cultures. COMPREHENSIVE Simultaneously tests for 43 targets and identifies them in more than 90% of positive blood cultures1 Sepsis Management Elevated Early identification and treatment of sepsis is essential to combat this leading cause of hospital deaths. The BIOFIRE BCID2 Panel can potentially help give back the time and resources you need to effectively manage and fight against sepsis. Shorten Time to Effective Therapy Using the BIOFIRE BCID2 Panel alongside an antimicrobial stewardship program (ASP) can help clinicians more quickly determine appropriate targeted therapy and de-escalate antimicrobials.3 Catch and Correct Inappropriate Therapy Empiric antimicrobial therapy is inappropriate in about 30% of patients,